Recent Updates
Recently added Catalysts
OLMA Positive Sentiment

Olema Oncology to Participate in Upcoming Investor Conferences in November

Wednesday, November 1, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Olema Oncology, a clinical-stage biopharmaceutical company, has announced its participation in two upcoming investor conferences in November. The CEO, Dr. Sean P. Bohen, will engage in a Fireside Chat at the Jefferies London Healthcare Conference and the Evercore ISI HealthCONx Conference. The events aim to boost investor engagement and visibility for the company as it focuses on targeted therapies for women's cancers. Live webcasts of the sessions will be available on Olema's investor relations website, ensuring wider access to stakeholders.
Price reaction · baseline $13.29 (2023-10-31 close) · hit after-hours · 1 other OLMA headline(s) in the window, move may be shared
day 0 close
+12.4%
day 1 · peak
+18.4%
day 3
+13.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Olema Oncology is actively engaging with investors through major conferences.
  • The participation of Dr. Sean P. Bohen can enhance the company's visibility.
  • Webcasts of the events will be made available, increasing accessibility.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+73%
120-day peak, hindsight
Typical move
8%
average across 7 past catalysts
Cash runway
~30 mo
Minimal dilution risk
Lead asset
Palazestrant
Phase 3 · Breast Cancer

Full Press Release Details

SAN FRANCISCO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers, today announced that the Company will present at the following upcoming investor conferences in November:
Sean P. Bohen, M.D., Ph.D., President and Chief Executive Officer, will participate in a Fireside Chat at the Jefferies London Healthcare Conference at The Waldorf Hilton in London, UK, on Wednesday, November 15, 2023, at 12:30 p.m. GMT (7:30 a.m. ET).
Dr. Bohen will participate in a Fireside Chat at the 6th Annual Evercore ISI HealthCONx Conference in Miami, FL, on Wednesday, November 29, 2023, at 1:20 p.m. ET.
A live webcast of the Fireside Chats and any accompanying presentation materials will be available under the News & Events section of Olema’s investor relations website at ir.olema.com. The webcasts will be archived for at least 30 days.
About Olema Oncology

Frequently Asked Questions

When will Olema Pharmaceuticals present at the investor conferences?

Olema Pharmaceuticals will present at two conferences in November 2023.

Who will speak at the Jefferies London Healthcare Conference?

Sean P. Bohen, M.D., Ph.D., will participate in the Fireside Chat.

Where is the 6th Annual Evercore ISI HealthCONx Conference held?

The conference takes place in Miami, FL.

Will the Fireside Chats be available online?

Yes, live webcasts and materials will be on Olema's investor relations site.

How long will the webcasts be archived?

The webcasts will be archived for at least 30 days.

ShareAdd on Google
Tags: OLMA Viatris Investor Conferences Healthcare Olema Oncology biopharmaceuticals investor conferences Sean Bohen women's cancers
Last updated: Nov 1, 2023

Biotech snapshot

Cash runway
$461M liquidity · $15M/mo burn
~30 mo
Minimal dilution risk
Lead asset
PalazestrantPhase 3
Breast Cancer →

Catalyst track record

+73%
best trade around OLMA's most recent catalyst

Peak hindsight return over a 120-day window, across 7 tracked FDA/PDUFA catalysts for OLMA.

See every catalyst's timing & PoA →